Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.

Sirohi K, Sripada A, Verma M, Varma R, Liu S, Yadav S, Sahu A, Manka L, Guntur VP, Gorska MM, Alam R. CBX7 functions as a methylation-dependent inducer of gene transcription and regulator of cytosolic signaling in lymphoid cells. Sci Adv. 2026 Feb 13; 12(7):eadj4926.

Wilburn AN, Korkmaz RÜ, McAlees JW, Hargis JM, Shirdel S, Lingel I, Watanabe-Chailland M, Romick-Rosendale L, Schmudde I, Bridges JP, Chougnet CA, Deshmukh H, Zacharias WJ, Köhl J, Konig P, Laumonnier Y, Rothenberg M, Haslam DB, Lewkowich IP. Maternal antibiotic exposure-mediated alterations in basal, and allergen-induced lung function are associated with altered recruitment of eosinophils to the developing lung. Front Immunol. 2025; 16:1715675.

Navanandan N, Hagopian E, Brinton JT, Tanverdi M, Edid A, Linn C, Sulbaran H, Florin TA, Mistry RD, Seibold MA, Szefler SJ, Liu AH, Hamlington KL. Oscillometry Measures the Response to Acute Asthma Therapy in the Pediatric Emergency Department. Ann Am Thorac Soc. 2025 Dec; 22(12):1900-1910.

Stanislawski MA, Litkowski E, Arehart CH, Luo K, Gilmore N, Lange LA, Lange EM, Barnes K, Avery CL, Meyer KA, Holguin F, North KE, Burk RD, Kaplan RC. Relationships among host genetics, gut microbiota, and asthma in US Hispanic/Latino adults. Nat Commun. 2025 Nov 20; 16(1):10223.

George M, Chipps BE, Beuther DA, McCann W, Reibman J, Wise RA, Zeiger RS, Gilbert I, Eudicone JM, Gandhi HN, Coyne KS, Harding G, Cutts K, Ross M, Murphy KR. What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251384465.

Palmu T, Lehtonen J, Elding Larsson H, Lynch KF, Jonsdottir B, Cilio C, Schatz D, Rewers M, Hyöty H, Lönnrot M. Association of fever and infections with the subsequent risk of atopic diseases in children with genetic susceptibility for T1D: Results from the TEDDY cohort study. Pediatr Allergy Immunol. 2025 Oct; 36(10):e70209.

Oberle AJ, Abbas F, Adrish M, Agache I, Conroy M, Coz Yataco AO, Little FF, Mammen MJ, Anand MP, Reddy R, Solanki N, Holguin F. Biologic Management in Severe Asthma for Adults: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2026 Feb; 169(2):336-348.

Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.

Wang E, Henley W, Larenas-Linnemann D, Bulathsinhala L, Tran TN, Wechsler ME, Aaron SD, Al-Ahmad M, Al-Lehebi R, Altraja A, Barker P, Beastall A, Belevskiy AS, Bergeron C, Bjermer L, Björnsdóttir US, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Carter V, Chapman KR, Chapman N, Christoff GC, Cosio BG, Costello RW, Fingleton J, Fonseca JA, Gaga M, Gibson PG, Hansen S, Heaney LG, Heffler E, Hew M, Horiguchi T, Hoyte F, Hubbard RB, Iwanaga T, Jackson DJ, Katial R, Koh MS, Kostikas K, Kuna P, Lehmann S, Lehtimäki L, Louis R, Lúdvíksdóttir D, Lugogo N, Mahboub B, Martin N, Máspero J, Menzies-Gow AN, Mohan A, Murray RB, Nagano T, Papadopoulos NG, Papaioannou AI, Patel PH, Perez-de-Llano L, Perng DW, Peters MJ, Pfeffer PE, Pitrez PM, Pleasants RA, Popov TA, Porsbjerg CM, Puggioni F, Quinton A, Rhee CK, Sadatsafavi M, Salvi S, Scioscia G, Sheu CC, Sirena C, Taillé C, Taube C, Torres-Duque CA, Tsai MJ, Tunsäter A, Ulrik CS, Price DB. Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach. J Allergy Clin Immunol Pract. 2025 Dec; 13(12):3296-3315.